Antidiarrheal effects of L-histidine-supplemented rice-based oral rehydration solution in the treatment of male adults with severe cholera in Bangladesh: A double-blind, randomized trial

Journal of Infectious Diseases

Volumn 191, Issue 9, 2005, Pages 1507-1514

  Rabbani, Golam H ^a,d   Sack, David A ^a   Ahmed, Shamsir ^a   Peterson, Johnny W ^b   Saha, Shyamal K ^a   Marni, Farzana ^a   Thomas, Peter ^c  

^a ICDDRB Clinical Sciences Division   (Bangladesh)

^b University of Texas Medical Branch School of Medicine   (United States)

^c CATO RESEARCH LTD   (United States)

^d ICDDR B Centre for Health and Population Research   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; HISTIDINE; INFUSION FLUID; ORAL REHYDRATION SOLUTION;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BANGLADESH; CHOLERA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FECES; FLUID INTAKE; FREQUENCY ANALYSIS; HEPATOBILIARY DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RICE; SUPPLEMENTATION; URINE; VIBRIO CHOLERAE; VOMITING; WEIGHT;

ADULT; ANTIDIARRHEALS; BANGLADESH; BLOOD PRESSURE; CHOLERA; DIARRHEA; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FECES; FLUID THERAPY; HEART RATE; HISTIDINE; HUMANS; MALE; VIBRIO CHOLERAE;

EID: 17644405429     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/428449     Document Type: Article

References (27)

1. Pan American Health Organization. Cholera in the Americas. Bull Pan Am Health Organ 1991; 25:267-73.
2. Siddique AK, Salam A, Islam MS, et al. Why treatment centers failed to prevent cholera deaths among Rwandan refugees in Goma, Zaire. Lancet 1995; 345:359-61.
3. Pierce NF, Robinson D, Rigal J, Dualeh M. Cholera treatment. Lancet 1994; 344:1022.
4. Rabbani GH. The search for a better oral rehydration solution for cholera. N Engl J Med 2000; 342:345-7.
5. Rabbani GH, Greenough WB, Holmgren J, Lonnroth I. Chlorpromazine reduces fluid-loss in cholera. Lancet 1979; 1:410-2.
6. Rabbani GH, Greenough WB, Holmgren J, Kirkwood B. Controlled trial of chlorpromazine as an antisecretory agent in patients with cholera hydrated intravenously. Brit Med J (Clin Res Ed) 1982; 284:1361-4.
7. Rabbani GH, Butler T, Bardhan PK, Islam A. Reduction of fluid-loss in cholera by nicotinic acid: a randomised controlled trial. Lancet 1983; 2:1439-42.
8. Rabbani GH, Butler T, Knight J, Sanyal SC, Alam K. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis 1987; 155:979-84.
9. Peterson JW, Boldogh I, Popov VL, Saini SS, Chopra AK. Anti-inflammatory and antisecretory potential of histidine in Salmonella-challenged mouse small intestine. Lab Invest 1998; 78:523-34.
10. Moss J, Vaughan M. Cholera toxin and E. coli enterotoxins and their mechanisms of action. In: Hardegree MC, Tu AT, eds. Bacterial toxins: handbook of natural toxins. Vol 4. New York: Marcel-Dekker, 1988:39-87.
11. Speelman P, Rabbani GH, Bukhave K, Rask-Madsen J. Increased concentrations of jejunal prostaglandin E2 in patients with acute cholera. Gut 1985; 26:188-93.
12. Peterson JW, Molina NC, Houston CW, Fader RC. Elevated cAMP in intestinal epithelial cells during experimental cholera and salmonellosis. Toxicon 1983; 21:761-75.
13. Peterson JW, Jackson CA, Reitmyer JC. Synthesis of prostaglandins in cholera toxin-treated Chinese hamster ovary cells. Microb Pathog 1990; 9:345-53.
14. Peterson JW, Whipp SC. Comparison of the mechanisms of action of cholera toxin and the heat-stable enterotoxins of Escherichia coli. Infect Immun 1995; 63:1452-61.
15. 2 activity is reduced by chemical reaction with L-histidine. Biochim Biophys Acta 2001; 1537:27-41.
16. Floyd JC Jr, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest 1966; 45:1487-502.
17. Rabbani GH, Sack DA, Choudhury MR. Vibrio cholerae. In: Miliotis MD, Bier JW, eds. International handbook of foodborne pathogens. New York: Marcel-Dekker, 2003:217-35.
18. Rabbani GH, Greenough WB. Pathogenesis and clinical aspects of cholera. In: Barua D, Grenough WB, eds. Cholera. Boston: Plenum Press, 1992:209-28.
19. Khan WA, Bennish ML, Seas C, et al. Randomised controlled comparison of single-dose ciprofloxadn and doxycycline for cholera caused by Vibrio cholerae. Lancet 1996; 348:296-300.
20. Zaman K, Yunus M, Rahman A, Chowdhury HR, Sack DA. Efficacy of a packaged rice oral rehydration solution among children with cholera and cholera-like illness. Acta Paediatr 2001; 90:505-10.
21. Gore SM, Fontaine O, Pierce NF. Impact of rice based oral redydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ 1992; 304:287-91.
22. Rabbani GH. Cholera. In: Robert RE, ed. Conn's current therapy. Philadelphia: WB Saunders, 2000:72-4.
23. Patra FC, Mahalanabis D, Jalan KN, Maitra TK, Sen A, Banerjee P. A controlled clinical trial of rice and glycine-containing oral rehydration solution in acute diarrhoea in children. J Diarrhoeal Dis Res 1986; 4:16-9.
24. Patra FC, Mahalanabis D, Jalan KN, Sen A, Banerjee P. In search of a super solution: controlled trial of glycine-glucose oral rehydration solution in infantile diarrhoea. Acta Paediatr Scand 1984; 73:18-21.
25. Zlotkin SH. Nutrient interactions with total parenteral nutrition: effects of histidine and cysteine on urinary zinc excretion. J Pediatr 1989; 114:859-64.
26. Henkin RI. New aspects in the control of food intake and appetite. Ann NY Acad Sci 1977; 300:321-33.
27. Sitton NG, Dixon JS, Astbury C, Francis RJ, Bird HA, Wright V. Kinetic investigations into the possible cause of low serum histidine in rheumatoid arthritis. Ann Rheum Dis 1988; 47:48-52.